Regulation of Oligodendrocyte Differentiation and Myelination by Nuclear Receptors: Role in Neurodegenerative Disorders

Adv Exp Med Biol. 2016:949:287-310. doi: 10.1007/978-3-319-40764-7_14.

Abstract

During development and through adulthood, differentiation of diverse cell types is controlled by specific genetic and molecular programs for which transcription factors are master regulators of gene expression. Here, we present an overview of the role of nuclear receptors and their selective pharmacological modulators in oligodendrocytes linage, their role in myelination and remyelination and their potential use as a therapeutic strategy for demyelinating diseases. We discuss several aspects of nuclear receptors including: (1) the biochemistry of nuclear receptors superfamily; (2) their role on stem cells physiology, focusing in differentiation and cell removal; (3) the role of nuclear receptor in the oligodendrocytes cell linage, from oligodendrocyte progenitors cells to mature myelinating cells; and (4) the therapeutics opportunities of nuclear receptors for specific demyelinating diseases.

Keywords: Alzheimer’s disease; Demyelinating diseases; Nuclear receptors; Oligodendrocytes.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adrenoleukodystrophy / drug therapy
  • Adrenoleukodystrophy / genetics*
  • Adrenoleukodystrophy / metabolism
  • Adrenoleukodystrophy / pathology
  • Alzheimer Disease / drug therapy
  • Alzheimer Disease / genetics*
  • Alzheimer Disease / metabolism
  • Alzheimer Disease / pathology
  • Animals
  • COUP Transcription Factors / agonists
  • COUP Transcription Factors / genetics
  • COUP Transcription Factors / metabolism
  • Cell Differentiation
  • Cell Lineage
  • Drugs, Investigational / therapeutic use
  • Gene Expression Regulation
  • Humans
  • Liver X Receptors / agonists
  • Liver X Receptors / genetics
  • Liver X Receptors / metabolism
  • Neuroprotective Agents / therapeutic use
  • Oligodendroglia / drug effects
  • Oligodendroglia / metabolism*
  • Oligodendroglia / pathology
  • Orphan Nuclear Receptors
  • Peroxisome Proliferator-Activated Receptors / agonists
  • Peroxisome Proliferator-Activated Receptors / genetics
  • Peroxisome Proliferator-Activated Receptors / metabolism
  • Receptors, Cytoplasmic and Nuclear / agonists
  • Receptors, Cytoplasmic and Nuclear / genetics
  • Receptors, Cytoplasmic and Nuclear / metabolism
  • Receptors, Retinoic Acid / agonists
  • Receptors, Retinoic Acid / genetics*
  • Receptors, Retinoic Acid / metabolism
  • Stem Cells / drug effects
  • Stem Cells / metabolism*
  • Stem Cells / pathology

Substances

  • COUP Transcription Factors
  • Drugs, Investigational
  • Liver X Receptors
  • NR2E1 protein, human
  • Neuroprotective Agents
  • Orphan Nuclear Receptors
  • Peroxisome Proliferator-Activated Receptors
  • Receptors, Cytoplasmic and Nuclear
  • Receptors, Retinoic Acid